BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Liu H, Luo X, Wang Y, Liu Y, Jin H, Liu Z, Yang W, Yu P, Zhang L, Zhang L. Design, synthesis and biological activities of 2,3-dihydroquinazolin-4(1H)-one derivatives as TRPM2 inhibitors. Eur J Med Chem 2018;152:235-52. [PMID: 29723786 DOI: 10.1016/j.ejmech.2018.04.045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Siddiqui MM, Nagargoje AA, Akolkar SV, Sangshetti JN, Khedkar VM, Pisal PM, Shingate BB. [HDBU][HSO4]-catalyzed facile synthesis of new 1,2,3-triazole-tethered 2,3-dihydroquinazolin-4[1H]-one derivatives and their DPPH radical scavenging activity. Res Chem Intermed. [DOI: 10.1007/s11164-021-04639-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z. Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors. Eur J Med Chem 2021;225:113750. [PMID: 34416664 DOI: 10.1016/j.ejmech.2021.113750] [Reference Citation Analysis]
3 Ali ES, Rychkov GY, Barritt GJ. TRPM2 Non-Selective Cation Channels in Liver Injury Mediated by Reactive Oxygen Species. Antioxidants (Basel) 2021;10:1243. [PMID: 34439491 DOI: 10.3390/antiox10081243] [Reference Citation Analysis]
4 Dutta A, Trivedi P, Gogoi D, Chetia P, Chaturvedi V, Sarma D. Anti-TB evaluation of novel 2,3-dihydroquinazolin-4(1H)-ones and in silico studies of the active compounds. Med Chem Res 2021;30:1366-76. [DOI: 10.1007/s00044-021-02733-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wei Y, Zhang M, Lyu Z, Yang G, Tian T, Ding M, Zeng X, Xu F, Wang P, Li F, Liu Y, Cao Z, Lu J, Hong X, Wang H. Benzothiazole Amides as TRPC3/6 Inhibitors for Gastric Cancer Treatment. ACS Omega 2021;6:9196-203. [PMID: 33842788 DOI: 10.1021/acsomega.1c00514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L. The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo. J Med Chem 2021;64:3976-96. [PMID: 33784097 DOI: 10.1021/acs.jmedchem.0c02129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ragab A, Fouad SA, Ali OAA, Ahmed EM, Ali AM, Askar AA, Ammar YA. Sulfaguanidine Hybrid with Some New Pyridine-2-One Derivatives: Design, Synthesis, and Antimicrobial Activity against Multidrug-Resistant Bacteria as Dual DNA Gyrase and DHFR Inhibitors. Antibiotics (Basel) 2021;10:162. [PMID: 33562582 DOI: 10.3390/antibiotics10020162] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
8 Wang Q, Liu N, Ni YS, Yang JM, Ma L, Lan XB, Wu J, Niu JG, Yu JQ. TRPM2 in ischemic stroke: Structure, molecular mechanisms, and drug intervention. Channels (Austin) 2021;15:136-54. [PMID: 33455532 DOI: 10.1080/19336950.2020.1870088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang H, Zhao S, Yu J, Yang W, Liu Z, Zhang L. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading? Drug Discov Today 2020;25:2326-34. [PMID: 33065292 DOI: 10.1016/j.drudis.2020.09.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Lee B, Willis AC, Ward JS, Smith WT, Lan P, Banwell MG. Iterative Suzuki-Miyaura Cross-coupling/Bromo-desilylation Reaction Sequences for the Assembly of Chemically Well-defined, Acyclic Oligopyrrole/Benzenoid Hybrids Embodying Mixed Modes of Connectivity. Chem Asian J 2020;15:3059-81. [PMID: 32749069 DOI: 10.1002/asia.202000740] [Reference Citation Analysis]
11 Fernández-Ballester G, Fernández-Carvajal A, Ferrer-Montiel A. Targeting thermoTRP ion channels: in silico preclinical approaches and opportunities. Expert Opin Ther Targets 2020;24:1079-97. [PMID: 32972264 DOI: 10.1080/14728222.2020.1820987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhang H, He X, Wang X, Yu B, Zhao S, Jiao P, Jin H, Liu Z, Wang K, Zhang L, Zhang L. Design, synthesis and biological activities of piperidine-spirooxadiazole derivatives as α7 nicotinic receptor antagonists. Eur J Med Chem 2020;207:112774. [PMID: 32882607 DOI: 10.1016/j.ejmech.2020.112774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Wang M, Li J, Dong S, Cai X, Simaiti A, Yang X, Zhu X, Luo J, Jiang LH, Du B, Yu P, Yang W. Silica nanoparticles induce lung inflammation in mice via ROS/PARP/TRPM2 signaling-mediated lysosome impairment and autophagy dysfunction. Part Fibre Toxicol 2020;17:23. [PMID: 32513195 DOI: 10.1186/s12989-020-00353-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
14 Mou J, Chen N, Zhao Y, Qi H, Meng S, Xiang R, Pei D. An Aqueous Facile Synthesis of 2,3-Dihydroquinazolin-4(1H)-One Derivatives by Reverse Zinc Oxide Micelles as Nanoreactor. Front Chem 2020;8:239. [PMID: 32391312 DOI: 10.3389/fchem.2020.00239] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Islam MS. Molecular Regulations and Functions of the Transient Receptor Potential Channels of the Islets of Langerhans and Insulinoma Cells. Cells 2020;9:E685. [PMID: 32168890 DOI: 10.3390/cells9030685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
16 Reddy MM, Sivaramakrishna A. Remarkably flexible quinazolinones—synthesis and biological applications. J Heterocyclic Chem 2020;57:942-54. [DOI: 10.1002/jhet.3844] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
17 Cruz-Torres I, Backos DS, Herson PS. Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX. Mol Pharmacol 2020;97:102-11. [PMID: 31772034 DOI: 10.1124/mol.119.117549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gondi SR, Bera AK, Westover KD. Green Synthesis of Substituted Anilines and Quinazolines from Isatoic Anhydride-8-amide. Sci Rep 2019;9:14258. [PMID: 31582788 DOI: 10.1038/s41598-019-50776-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Narasimhamurthy K, Girish Y, Thimmaraju N, Rangappa K. Utility of ZrO2–Al2O3 in the synthesis of 2,3-dihydroquinazolin-4(1H)-ones. Chemical Data Collections 2019;21:100230. [DOI: 10.1016/j.cdc.2019.100230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
20 Fourgeaud L, Dvorak C, Faouzi M, Starkus J, Sahdeo S, Wang Q, Lord B, Coate H, Taylor N, He Y, Qin N, Wickenden A, Carruthers N, Lovenberg TW, Penner R, Bhattacharya A. Pharmacology of JNJ-28583113: A novel TRPM2 antagonist. Eur J Pharmacol 2019;853:299-307. [PMID: 30965058 DOI: 10.1016/j.ejphar.2019.03.043] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
21 Zhang X, Li Z, Ding Q, Li X, Fan X, Zhang G. Alkylamino-Directed One-Pot Reaction of N -Alkyl Anilines with CO, Amines and Aldehydes Leading to 2,3-Dihydroquinazolin-4(1 H )-ones. Adv Synth Catal 2019;361:976-82. [DOI: 10.1002/adsc.201801267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]